483
Catalent Argentina S.A.I.C.Catalent Argentina S.A.I.C. – FDA 483, Aug 4, 2023
Record Details
An FDA inspection of Catalent Argentina S.A.I.C. in Buenos Aires, Argentina, revealed significant deficiencies in laboratory controls and facility design. The firm's analytical procedures for drug products were found to be inadequate, lacking proper method transfer verification and stability-indicating studies. Additionally, the facility's areas for preparing different products were not sufficiently separated, creating a risk of contamination and mix-ups.
View Company Profile
ID · cbabcbc7-9031-467b-b457-3a7b2e4658bc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.